10/12/2025
Lenacapavir PrEP: Why the Abdomen?
The Goal: A Six-Month Medicine Depot
Lenacapavir is a long-acting drug, meaning it must stay in the body for a very long time—in this case, six months—to provide continuous HIV protection. To achieve this, the medicine is formulated as a special, thick suspension.
When injected, this suspension doesn't dissolve quickly; instead, it forms a small, firm "drug depot" or reservoir of medicine under the skin. The body then slowly absorbs the drug from this depot over the next 26 weeks.
The injection is given subcutaneously (Sub-Q), which means it goes into the fatty layer (adipose tissue) just beneath the skin, not deep into the muscle like many vaccines. The fatty tissue is important because it has less blood flow compared to muscle. This low blood flow helps ensure the drug is released very slowly and steadily into the bloodstream over the required six-month period, maintaining protective drug levels.
The abdomen(stomach) is the preferred and authorized site for this injection because it typically provides a sufficient and easily accessible layer of subcutaneous (fatty) tissue. This area is ideal for hosting the small, slow-release drug depot. Healthcare providers are trained to administer the two required injections (given a few inches apart) safely into this fatty layer, ensuring the medicine is released correctly for its long-acting effect.
The injection is given in the stomach because it is the best place to create a safe, slow-release "medicine pocket" that lasts for six months. This method ensures you are protected every day without having to remember to take a daily pill. Hope you now understand why they are giving you this drug in your stomach?
